Zoledronic Acid Monohydrate CAS 165800-06-6 Mimo ≥99.0% API Iwa Mimo Giga
Olupese pẹlu Giga ti nw ati Idurosinsin Didara
Orukọ Kemikali: Zoledronic Acid Monohydrate
CAS: 165800-06-6
Bisphosphonate ti o lagbara pupọ ati amuṣiṣẹ ti PKC
API Didara Giga, Iṣelọpọ Iṣowo
Orukọ Kemikali | Zoledronic Acid Monohydrate |
Nọmba CAS | 165800-06-6 |
NỌMBA CAT | RF-API56 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
Fọọmu Molecular | C5H12N2O8P2 |
Òṣuwọn Molikula | 290.1 |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Funfun tabi Fere Crystalline Powder |
Idanimọ | IR Spectrum;HPLC ChromatogramUV-Vis: Gbigba ti o pọju wa ni 210nm |
pH | 2.0 ~ 4.0 |
Solubility | Tiotuka diẹ ninu 0.1N sodium hydroxide ojutu, die-die tiotuka ninu omi ati 0.1N hydrochloric acid, Oba insoluble ni ethanol. |
wípé ati Awọ | Ojutu yẹ ki o jẹ kedere ati awọ;ti o ba ti opalescent, ko yẹ ki o diẹ ẹ sii opalescent ju idaduro itọkasi 1;ti o ba ti awọ, ko siwaju sii intensely awọ ju Y2 |
Aimọ Kanṣoṣo | ≤0.50% |
Lapapọ Awọn Aimọ | ≤1.0% |
Pipadanu lori Gbigbe | 5.0% ~ 8.0% |
Kloride | ≤0.02% |
Phosphate | ≤0.50% |
Fọsifiti | ≤0.50% |
Awọn irin Heavy | ≤10ppm |
Mimo | ≥99.0% |
Igbeyewo Standard | Standard Enterprise |
Lilo | API |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
Zoledronic acid monohydrate jẹ bisphosphonate ti o ni agbara pupọ ati oluṣeto ti PKC.Zoledronic acid monohydrate jẹ heterocyclic bisphosphonate ti a ṣe akiyesi pe o ni agbara ti o ga julọ ti bisphosphonates fun idinku ti isọdọtun egungun ti o pọ si ati pe a ti lo ni ọpọlọpọ awọn ẹkọ osteoporosis.Zoledronic acid monohydrate jẹ inhibitor ti ASM ati FDPS ati amuṣiṣẹ ti PKC.Zoledronic acid (zoledronate) jẹ inhibitor resorption egungun bisphosphonate, inhibitor ti farnesyl diphosphate (FPP) synthase eyiti o jẹ abajade ni idinamọ isale ti iṣẹ osteoclast ati dinku isọdọtun egungun ati iyipada.O ti lo lati ṣe itọju osteoporosis postmenopausal, arun Paget, hypercalcemia, ati pẹlu chemotherapy akàn lati ṣe itọju ibajẹ egungun ti o ṣẹlẹ nipasẹ akàn ti o ti tan si awọn egungun.